Snapshot from Jul 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Business ESG rating achievement

WuXi Biologics retains MSCI AAA ESG rating

Analysis based on 6 articles · First reported Jul 08, 2026 · Last updated Jul 08, 2026

Sentiment
20
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The sustained MSCI AAA ESG rating and index inclusion enhance ADMA Biologics' reputation among institutional investors focused on sustainability, potentially attracting ESG-focused capital. This recognition may positively influence the company's stock price and valuation in the biopharmaceutical sector.

Biopharmaceutical Contract Research and Manufacturing

ADMA Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced on July 8, 2026, that it has achieved MSCI's highest AAA ESG rating and been included in the MSCI 2026 Selection Indexes for the fourth consecutive year. This recognition was attained under the new MSCI ESG Model 5.0, which caused rating changes for approximately 37% of rated issuers. The company's sustained performance across key ESG topics such as Product Safety and Quality, Human Capital Development, Corporate Governance, and Climate Change contributed to this achievement. Dr. Chris Chen, CEO and Chairman of the ESG Committee, highlighted that this validates the company's sustainability efforts. ADMA Biologics has also received recognition from other leading ESG rating agencies including EcoVadis, S&P Dow Jones Indices, CDP, Sustainalytics, FTSE4Good Index Series, ISS ESG, and Hang Seng Corporate Sustainability Index Series.

70 ADMA Biologics achieved MSCI AAA ESG rating
stock
ADMA Biologics is the subject of the event; it retained its MSCI AAA ESG rating and was included in the MSCI Selection Indexes for the fourth consecutive year, reinforcing its sustainability leadership.
Importance 100.0 Sentiment 20.0
stock
MSCI is the rating agency that awarded the AAA ESG rating and included ADMA Biologics in its Selection Indexes; the event highlights MSCI's ESG rating system.
Importance 80.0 Sentiment 0.0
per
Chris Chen, as CEO and Chairman of the ESG Committee, commented on the achievement, representing the company's leadership.
Importance 30.0 Sentiment 10.0
priv
EcoVadis is mentioned as one of the ESG rating agencies that previously recognized ADMA Biologics with a Platinum Medal.
Importance 10.0 Sentiment 0.0
index
S&P Dow Jones Indices is mentioned as having included ADMA Biologics in its Best-in-Class World Index and Emerging Markets Index.
Importance 10.0 Sentiment 0.0
ngo
CDP is mentioned as having awarded ADMA Biologics 'A List' status for Climate Change, Water Security, and Supplier Engagement.
Importance 10.0 Sentiment 0.0
priv
Sustainalytics is mentioned as having given ADMA Biologics the highest negligible-risk rating and designated it as an industry and regional ESG Leader.
Importance 10.0 Sentiment 0.0
index
FTSE4Good Index Series is mentioned as having included ADMA Biologics in its index series.
Importance 10.0 Sentiment 0.0
priv
ISS ESG is mentioned as having given ADMA Biologics a 'Prime' designation.
Importance 10.0 Sentiment 0.0
index
Hang Seng Corporate Sustainability Index Series is mentioned as having included ADMA Biologics.
Importance 10.0 Sentiment 0.0
cnt
United States is mentioned as one of the countries where ADMA Biologics has employees.
Importance 5.0 Sentiment 0.0
cnt
China is mentioned as one of the countries where ADMA Biologics has employees.
Importance 5.0 Sentiment 0.0
cnt
Singapore is mentioned as one of the countries where ADMA Biologics has employees.
Importance 5.0 Sentiment 0.0
cnt
Germany is mentioned as one of the countries where ADMA Biologics has employees.
Importance 5.0 Sentiment 0.0
cnt
Republic of Ireland is mentioned as one of the countries where ADMA Biologics has employees.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.